Gini, G., Tani, M., Bassan, R., Tucci, A., Ballerini, F., Sampaolo, M., Merli, F., Re, F., Annibali, O., Liberati, A., Visco, C., Arcari, A., Storti, S., Fabbri, A., Musuraca, G., Zilioli, V., Cox, M., & Luminari, S. (n.d.). lENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B‐CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL). Hematological oncology, 37, 427–428. http://access.bl.uk/ark:/81055/vdc_100086206953.0x000046